Neurology Devices Global Market Outlook to 2028, with Profiles of Medtronic, Abbott, Terumo, Boston Scientific Corp., Natus Medical and Siemens Healthineers - ResearchAndMarkets.com
28 Dec 2023
DUBLIN--(BUSINESS WIRE)--The "Neurology Devices: Global Markets" report has been added to ResearchAndMarkets.com's offering.
The global neurology devices market was valued at $22.7 billion in 2022 and is forecast to reach $31.7 billion by the end of 2028, growing at a compound annual growth rate (CAGR) of 6.0% over the forecast period.
The increasing prevalence of neurological disorders, technological advancements in the field of neurology and growing healthcare expenditure are the major factors driving the growth of this market.
Aging Population: The growing worldwide elderly population is a significant driver of the neurology devices market. Neurodegenerative diseases (such as Alzheimer's and Parkinson's) and cerebrovascular diseases (stroke, aneurysms, stenosis) occur very frequently in older adults. This creates a need for neurology devices as they can both offer an accurate diagnosis of these diseases and monitor a patient's progress through the treatment process.
The increasing prevalence of neurological disorders such as Alzheimer's disease, Parkinson's disease, stroke, epilepsy and multiple sclerosis result in a substantial disease burden. The rising prevalence of these conditions and the increasing number of patients resistant to medication drive the demand for neurology devices. These devices help with early diagnosis and provide effective personalized treatment and monitoring.
Technological advancements are a significant driving factor fueling the growth of the neurology devices market. Technological advancements are instrumental in developing sophisticated and effective neurology devices to provide precision diagnostics, timely treatment and monitoring in order to improve patient outcomes and quality of life.
Growing awareness among individuals and healthcare professionals of the early symptoms of neurological disorders helps with early diagnosis and effective management and treatment of these conditions. Patients who are aware of these diseases are more likely to seek medical attention at the onset of symptoms. Accurate diagnosis at early stages often requires the use of neurological devices
Increasing research and development (R& D) investments drive the neurology devices market by leading to the development of advanced technologies that are more accurate, reliable and user friendly in terms of diagnosing and treating neurological disorders. R& D efforts also expand the scope of neurological indications for treatment, and this ultimately increases the capabilities of neurological diagnostic and treatment devices.
This report is a comprehensive study of the global market for neurology devices. It describes the neurology devices market and segments it by product type and region. Based on product type, the market is segmented into neurosurgical devices, neuromodulation devices, neurovascular devices and neurodiagnostic devices. The market is segmented by region into North America, Latin America, Europe, Asia-Pacific and Rest of the World (RoW).
This report examines the factors driving growth in the neurology devices market, and it reviews major players, established companies, and new entrants.
The Report Includes
20 data tables and 18 additional tables
An overview of the global markets for neurology devices
In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
Evaluation of the current market size and revenue growth prospects specific to neurology devices, accompanied by a comprehensive market share analysis categorized by product type, and geographical region
Discussion on the emerging technologies in neurology devices market and areas of focus to forecast the market into various segments and sub-segments
Assessment of the key drivers and constraints that will shape the market for neurology devices and discussion on the upcoming market opportunities
Detailed description of the competitive landscape, product mapping, major player's strategic initiatives, R&D activities, and other initiatives
Detailed profiles of leading market participants, including Medtronic, Abbott, Terumo, Boston Scientific Corp., Natus Medical Inc., and Siemens Healthineers
Key Attributes:
Report Attribute
Details
No. of Pages
102
Forecast Period
2023 - 2028
Estimated Market Value (USD) in 2023
$23.7 Billion
Forecasted Market Value (USD) by 2028
$31.7 Billion
Compound Annual Growth Rate
6.0%
Regions Covered
Global
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Market Background and Definitions
Neurology Devices
Neurosurgical Devices
Neuromodulation Devices
Neurovascular Devices
Neurodiagnostic Equipment
Diseases Background
Cerebral Aneurysms
Tremors
Chapter 4 Market Trends
Market Drivers
Aging Population
Neurology Disorders and Cancer Cases by Country
Penetration of Neurology Devices in Emerging Markets
Market Opportunity
Market Restraints
Chapter 5 Market Breakdown by Product Type
Neurosurgical Devices
Neuromodulation Devices
Neurovascular Devices
Neurodiagnostic Devices
Chapter 6 Market Breakdown by Region
Chapter 7 Emerging Trends/Technologies in the Neurology Devices Market
AI in Neurology
Wearable Neurology Devices
Precision Radiotherapy in Neurology
Stereotactic Radiosurgery
Stereotactic Body Radiation Therapy
Brain-Computer Interfaces (BCIs)
Chapter 8 Sustainability in Neurology Devices Market: An ESG Perspective
Chapter 9 Pipeline Analysis
Chapter 10 Competitive Landscape
Chapter 11 Company Profiles
Abbott
B. Braun
Danaher
Elekta
Koninklijke Philips
Livanova
Nihon Kohden
Penumbra
For more information about this report visit https://www.researchandmarkets.com/r/nrmmc3
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.